Rafferty Asset Management
ANIK icon

Rafferty Asset Management’s Anika Therapeutics ANIK Stock Holding History

Rafferty Asset Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-28,114
Closed -$730K – 1076
2023
Q2 		$730K Sell
28,114
-878
-3% -$23.5K ﹤0.01% 898
2023
Q1 		$833K Buy
28,992
+880
+3% +$26.2K 0.01% 844
2022
Q4 		$832K Sell
28,112
-240
-0.8% -$6.83K 0.01% 799
2022
Q3 		$675K Buy
28,352
+14,210
+100% +$327K 0.01% 788
2022
Q2 		$316K Sell
14,142
-15,499
-52% -$346K ﹤0.01% 906
2022
Q1 		$744K Buy
29,641
+6,363
+27% +$194K ﹤0.01% 842
2021
Q4 		$834K Buy
23,278
+8,586
+58% +$344K ﹤0.01% 951
2021
Q3 		$625K Sell
14,692
-6,025
-29% -$248K ﹤0.01% 994
2021
Q2 		$897K Sell
20,717
-7,774
-27% -$331K 0.01% 952
2021
Q1 		$1.16M Buy
28,491
+23,112
+430% +$877K 0.01% 740
2020
Q4 		$243K Sell
5,379
-6,512
-55% -$247K ﹤0.01% 922
2020
Q3 		$421K Buy
11,891
+4,549
+62% +$164K 0.01% 736
2020
Q2 		$277K Buy
+7,342
New +$242K ﹤0.01% 850
2020
Q1 		– Sell
-18,719
Closed -$971K – 609
2019
Q4 		$971K Sell
18,719
-5,192
-22% -$302K 0.01% 560
2019
Q3 		$1.31M Buy
23,911
+1,145
+5% +$58.8K 0.02% 482
2019
Q2 		$925K Buy
22,766
+2,108
+10% +$76.9K 0.02% 571
2019
Q1 		$625K Buy
+20,658
New +$708K 0.01% 626

Other funds holding ANIK

TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Rafferty Asset Management's ANIK Position: Q3 2023 in Review

Rafferty Asset Management sold out of Anika Therapeutics (ANIK) in Q3 2023, closing a stake of 28,114 shares — an estimated $730K sold.

Rafferty Asset Management first reported a position in ANIK in Q1 2019 and held it in 17 quarters. The position peaked at $1.31M in Q3 2019. 115 funds tracked by Wall St. Rank hold ANIK as of Q3 2023.

  • Rafferty Asset Management reported no remaining Anika Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Rafferty Asset Management sold 28,114 Anika Therapeutics shares in Q3 2023, an estimated $730K.
  • Rafferty Asset Management first reported a position in Anika Therapeutics in Q1 2019 and held it in 17 quarters.
  • Rafferty Asset Management's Anika Therapeutics position peaked at $1.31M in Q3 2019.
  • 115 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2023.

Based on Rafferty Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.